
    
      Secondary objectives include the evaluation of the following:

        -  Change from baseline of POP-Q scoring at 6 weeks, 6 months and 12 months post procedure,
           including evolution of treated or non-treated posterior compartments.

        -  The proportion of patients with anatomical prolapse (C/D), but who are asymptomatic.

        -  Change from baseline of mean quality-of-life scores.

        -  Evaluation of mesh properties from procedure date through study period.

        -  Peri-operative and post-treatment pain score assessment comparing the various anesthesia
           regimes used (Visual Analog Scale).

        -  Assessment of patient subjective outcomes for overall treatment effects and
           satisfaction.

        -  Objective evaluation of mesh shrinkage by standardized ultrasound measurements.
    
  